Home PharmTech Tariff Pause Reinforces Uncertainty Among Biopharma Professionals

Tariff Pause Reinforces Uncertainty Among Biopharma Professionals

by Newsroom


As Pharmaceutical Technology® Group was busy networking with industry leaders at INTERPHEX 2025 in New York City on April 2, United States President Donald Trump scheduled the announcement of what he called “Liberation Day” with a 10% baseline tariff on imported goods from most other countries in the world, effective April 5 (1).

One week later, in the early morning hours of April 9, Trump went ahead with levying reciprocal taxes on countries the president had felt engaged in unfair trading practices, according to an Associated Press report (1). Those tariffs were what, later that day, Trump then selected for a 90-day pause that briefly sent a…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC